Addex Therapeutics Aktie 2985075 / CH0029850754
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
04.12.2025 06:59:45
|
Press Release: Addex Therapeutics Reports 2025 -2-
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements about the intended use of proceeds of the offering. The words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release, are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, uncertainties related to market conditions. These and other risks and uncertainties are described in greater detail in the section entitled "Risk Factors" in Addex Therapeutics' Annual Report on Form 20-F, prospectus and other filings that Addex Therapeutics may make with the SEC in the future. Any forward-looking statements contained in this press release represent Addex Therapeutics' views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Addex Therapeutics explicitly disclaims any obligation to update any forward-looking statements.
(END) Dow Jones Newswires
December 04, 2025 01:00 ET (06:00 GMT)
Nachrichten zu Addex Therapeutics Ltd.
|
10:02 |
SPI-Wert Addex Therapeutics-Aktie: So viel Verlust hätte ein Investment in Addex Therapeutics von vor 3 Jahren eingebracht (finanzen.ch) | |
|
27.01.26 |
Freundlicher Handel in Zürich: SPI zum Ende des Dienstagshandels mit grünem Vorzeichen (finanzen.ch) | |
|
27.01.26 |
SPI-Handel aktuell: SPI-Börsianer greifen zu (finanzen.ch) | |
|
27.01.26 |
Dienstagshandel in Zürich: So performt der SPI aktuell (finanzen.ch) | |
|
27.01.26 |
Freundlicher Handel: SPI-Börsianer greifen zum Handelsstart zu (finanzen.ch) | |
|
26.01.26 |
Börse Zürich in Rot: SPI verbucht zum Ende des Montagshandels Verluste (finanzen.ch) | |
|
26.01.26 |
Börse Zürich: SPI schwächelt am Montagnachmittag (finanzen.ch) | |
|
21.01.26 |
Handel in Zürich: SPI präsentiert sich am Mittwochnachmittag schwächer (finanzen.ch) |
Analysen zu Addex Therapeutics Ltd.
3 Knaller-Aktien im BX Musterportfolio: KLA, Alphabet & BBVA mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ KLA
✅ Alphabet A
✅ BBVA (Banco Bilbao Vizcaya Argentaria)
https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Addex Therapeutics Ltd. | 0.05 | 0.00% |
|
| Addex Therapeutics Ltd (spons. ADRs) | 6.60 | -2.22% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Augen auf Fed und US-Tech-Bilanzen: SMI beendet Handel leichter -- DAX letztlich etwas tiefer -- US-Börsen schliessen wenig verändert -- Asiens Börsen schliessen mit GewinnenDer heimische Aktienmarkt zeigte sich zur Wochenmitte schwach. Der DAX tendierte ebenso zu Verlusten. An der Wall Street war keine klare Richtung zu erkennen. Die Börsen in Asien zeigten sich zur Wochenmitte fester.